goralatide has been researched along with Neurodegenerative Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balalaie, S; Kamarehei, M; Pejman, S; Pooyan, S; Riazi, G | 1 |
1 other study(ies) available for goralatide and Neurodegenerative Diseases
| Article | Year |
|---|---|
Ac-SDKP ameliorates the progression of experimental autoimmune encephalomyelitis via inhibition of ER stress and oxidative stress in the hippocampus of C57BL/6 mice.
Topics: Animals; Antioxidants; Apoptosis; Caspase 12; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Female; Hippocampus; Inflammation; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Neurodegenerative Diseases; Oligopeptides; Oxidation-Reduction; Oxidative Stress; Protein Disulfide-Isomerases; Transcription Factor CHOP | 2020 |